The Indian market still accounts for about 30-35 percent of the global business, the European market is another 35 percent, US is approximately 20 percent and…
In Conversation
"We have a longstanding track record of providing secure and effective product to doctors in Ecuador and therefore, LIFE is widely recognized by authorities and the…
"We want to jump on the growth wagon the biopharmaceutical industry will be experiencing over the next few years, which is why we introduced the GDP…
"Foreign investors and big foreign companies have waited for too long before making the move to acquire a polish wholesaler to further make it grow."
"In general, the Latvian pharmaceutical market is very small and often, given its size, is not very easy to negotiate prices."
Our global strategy is now to outlicense in many of the emerging markets to local large companies in countries such as Russia, Brazil and Colombia
"The company currently sells a vast array of products in segments that cover the entire spectrum of animal breeding, from aquaculture to pet care."
"Canada is a unique market in that we do not have a private arm to our healthcare system. This brings with it advantages and challenges."
"The key to our success is that we always understand the situation and have a direct approach, good contacts, and are always listening to each and…
"For the future health it is very important to implement Digital Single Market principles and free movement of personal health data cross border for research and…
"We want to be the number one among multinational companies in India as well as the most admired company in the country while continuing serving the…
"We are well-positioned to assist pharma companies in analyzing the medical cannabis landscape, understanding the implications on their core business and exploring market entry options if…
